A critical discovery in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer protector protein is frequently lost in various kinds of malignancies, resulting https://bookmarkspecial.com/story22131618/mini-antibodies-reactivate-the-p53-protein-a-potential-hope-for-tumor-treatment